octopamine has been researched along with Diabetes Mellitus, Type 2 in 2 studies
Octopamine: An alpha-adrenergic sympathomimetic amine, biosynthesized from tyramine in the CNS and platelets and also in invertebrate nervous systems. It is used to treat hypotension and as a cardiotonic. The natural D(-) form is more potent than the L(+) form in producing cardiovascular adrenergic responses. It is also a neurotransmitter in some invertebrates.
octopamine : A member of the class of phenylethanolamines that is phenol which is substituted at the para- position by a 2-amino-1-hydroxyethyl group. A biogenic phenylethanolamine which has been found to act as a neurotransmitter, neurohormone or neuromodulator in invertebrates.
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Schumann, U | 1 |
Jenkinson, CP | 1 |
Alt, A | 1 |
Zügel, M | 1 |
Steinacker, JM | 1 |
Flechtner-Mors, M | 1 |
Branch, A | 1 |
Zhang, Y | 1 |
Shen, P | 1 |
2 other studies available for octopamine and Diabetes Mellitus, Type 2
Article | Year |
---|---|
Sympathetic nervous system activity and anti-lipolytic response to iv-glucose load in subcutaneous adipose tissue of obese and obese type 2 diabetic subjects.
Topics: Adrenergic Agonists; Adult; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glucose; Glycerol; Hum | 2017 |
Genetic and Neurobiological Analyses of the Noradrenergic-like System in Vulnerability to Sugar Overconsumption Using a Drosophila Model.
Topics: Adrenergic Neurons; Animals; Appetite Regulation; Diabetes Mellitus, Type 2; Disease Models, Animal; | 2017 |